CRVO Stock Analysis: Buy, Sell, or Hold?
CRVO - CervoMed Inc. Common Stock
$3.26
-0.46 (-12.37%)
▼
5d:
-27.88%
30d:
+6.54%
90d:
-16.84%
WAIT
LOW Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: May 18, 2026
0d
Get Alerted When CRVO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called CRVO this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CRVO is down 27.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CRVO is down 27.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CRVO is currently trading at $3.26, which is considered fair relative to its 30-day fair value range of $2.61 to $3.68.
Technical Outlook: Technically, CRVO is in a strong downtrend. Immediate support is located at $2.13, while resistance sits at $7.45. Short-term momentum is weak, with the stock down 12.4% recently.
Market Sentiment: CRVO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $19.50 (+498.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CRVO is in a strong downtrend. Immediate support is located at $2.13, while resistance sits at $7.45. Short-term momentum is weak, with the stock down 12.4% recently.
Market Sentiment: CRVO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $19.50 (+498.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.61 -
$3.68
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
81.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-12.4%)
- BULLISH: Trading 498.2% below Wall St target ($19.50)
- WARNING: Recommendation downgraded due to -27.9% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$2.61 -
$3.68
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$2.13
Resistance Level
$7.45
Current Trend
Strong Downtrend
Technical data as of
Jun 17, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.35
Wall Street Target
$19.50
(+498.2%)
Revenue Growth (YoY)
-99.6%
Share & Embed Analysis
Last updated: June 25, 2026 4:31 AM ET
Data refreshes hourly during market hours. Next update: 5:31 AM
Data refreshes hourly during market hours. Next update: 5:31 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRVO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 61 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 60 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 60 BUY |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$109 | 61 BUY |
